share_log

Skylight Health Announces Earnings Call and Corporate Update

Skylight Health Announces Earnings Call and Corporate Update

Skylight Health宣布财报电话会议和公司最新情况
GlobeNewswire ·  2022/05/12 05:29

TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced that its financial results for the first quarter of 2022 will be released after the close of market on May 16th, 2022. The Company will host a conference call at 8:00am EDT on the morning of May 17th, 2022 to discuss the financial results and outlook for the Company.

环球通讯社多伦多,2022年5月11日-美国多州初级保健管理集团天光健康集团(纳斯达克:SLHG;多伦多证券交易所股票代码:SLHG;多伦多证券交易所股票代码:SLHG)今天宣布,其2022年第一季度的财务业绩将于2022年5月16日市场收盘后公布。该公司将于美国东部时间2022年5月17日上午8:00举行电话会议,讨论公司的财务业绩和前景。

If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call.

如果您想参加电话会议,可以在下面找到详细信息。请在通话开始前大约10分钟拨打电话。

Conference Call Details

电话会议详细信息

Date: May 17, 2022
Time: 8:00am Eastern
US/Canada Toll Free Dial In: 1-800-319-4610
Toronto Local Dial In: 416-915-3239
International Dial In: +1-604-638-5340
Call Name: Skylight Health Group First Quarter 2022 Financial Results
日期: 2022年5月17日
时间: 东部时间上午8:00
美国/加拿大免费拨入: 1-800-319-4610
多伦多本地拨入: 416-915-3239
国际拨入: +1-604-638-5340
呼叫名称: 天光健康集团2022年第一季度财务业绩


The Company is also announcing that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2021 (the "Form 20-F") as established in Nasdaq Listing Rule 5250(c)(1) (the "Rule"). The Form 20-F is the required annual report that the Company should file with the US Securities and Exchange Commission ("SEC") that incorporates its annual financial statements which were completed and previously filed with the SEC under Form 6-K on March 30, 2022. Due to the additional PCAOB audit requirements for the fiscal years ended December 31, 2020 and 2019, which were not required upon the Company's initial listing in the US and on Nasdaq, the Company has not been able to file the Form 20-F on time.


本公司亦宣布,已收到纳斯达克证券市场(“纳斯达克”)上市资格审核部发出通知(“通知”),因其未能按照“纳斯达克上市规则”第5250(C)(1)条(“该规则”)的规定,及时提交其截至2021年12月31日止年度的20-F表格年报(“20-F表格”)。Form 20-F是公司应向美国证券交易委员会(“美国证券交易委员会”)提交的必需的年度报告,其中包括已于2022年3月30日以Form 6-K向美国证券交易委员会完成并提交的年度财务报表。由于PCAOB对截至2020年12月31日和2019年12月31日的财政年度的额外审计要求,而这些要求在公司在美国和纳斯达克首次上市时并未被要求,公司未能按时提交20-F表格。

While the Company works to rectify this non-compliance with its US filing requirements, trading of the Company's shares continues without issue on Nasdaq and TSX-V.

虽然公司正在努力纠正这种不遵守其美国备案要求的行为,但公司股票在纳斯达克和多伦多证交所-V的交易仍未发行。

The Notice also disclosed that under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until July 5, 2022, to submit a plan to regain compliance with the Rule. Upon Nasdaq approval of the Company's plan, it may grant an exception of up to 180 calendar days from the due date of the Form 20-F, or until October 31, 2022, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq.

通知还披露,根据纳斯达克规则,公司有60个日历日的时间在收到通知后,或在2022年7月5日之前提交计划,以重新遵守规则。在纳斯达克批准公司的计划后,公司可给予自20-F表格到期日起最长180个历日的例外,或至2022年10月31日为止,以重新获得合规。然而,不能保证纳斯达克会接受公司恢复合规的计划,也不能保证公司能够在纳斯达克批准的任何延长期内恢复合规。

The Company is also announcing the issuance of 318,259 shares which is the final issuance related to its previously announced acquisition of River City Medical Associates announced on February 4, 2021. All issued shares will be subject to a four-month hold from the date of issuance and is subject to TSX-V approval. This is the last issuance of shares being made in relation to this acquisition.

该公司还宣布发行318,259股,这是与2021年2月4日宣布的对River City Medical Associates的收购相关的最后一次发行。所有已发行股票将自发行之日起持有四个月,并有待多伦多证交所-V的批准。这是与此次收购相关的最后一次股票发行。

About Skylight Health Group 

关于天光健康集团

Skylight Health Group (NASDAQ:SLHG;TSXV:SLHG) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools including proprietary technology, data analytics and infrastructure. In an FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on volume of patients per day. In a VBC model, the providers offer care that is aimed at keeping patients healthy and minimize unnecessary health expenditures that are not proven to maintain the patient's well-being. This places an emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.

天光健康集团(纳斯达克:SLHG;多伦多证券交易所股票代码:SLHG)是一家医疗服务和技术公司,致力于积极影响患者的健康结果。该公司经营着美国多个州的初级保健保健网络,由物理实践组成,提供从初级保健、专科、联合保健和实验室/诊断测试在内的一系列服务。该公司专注于通过包括专有技术、数据分析和基础设施在内的工具,帮助小型独立实践从传统的按服务收费(FFS)模式转变为基于价值的护理(VBC)模式。在FFS模式中,付款人(商业和政府保险公司)根据相遇的方法进行报销。这将重点放在每天的病人数量上。在VBC模式中,提供者提供的护理旨在保持患者的健康,并将未经证明能够维持患者福祉的不必要的医疗支出降至最低。这就把重点放在质量而不是数量上。VBC将改善患者的预后,降低交付成本,并从现有实践中推动更强劲的财务业绩。

Forward Looking Statements

前瞻性陈述

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent our current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this release. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as "look forward," "believe," "continue," "building," or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings we make with the Canadian and United States securities regulators, including the Securities and Exchange Commission, available at: www.sec.gov, and Canadian Securities Administrators, available at , and on our website, at skylighthealthgroup.com.

本新闻稿可能包括可能被视为适用证券法意义上的前瞻性的预测、估计或其他信息。虽然这些前瞻性陈述代表了我们目前的判断,但它们会受到风险和不确定性的影响,这些风险和不确定性可能会导致实际结果大不相同。告诫您不要过度依赖这些前瞻性陈述,这些陈述仅反映我们截至本新闻稿发布之日的观点。请记住,我们没有义务根据新信息或未来事件修改或公开发布对这些前瞻性陈述的任何修订结果。在此使用时,诸如“展望”、“相信”、“继续”、“建设”等词语或此类词语的变体和类似表达旨在识别前瞻性陈述。可能导致实际结果与我们在此作出的任何前瞻性陈述中预期的结果大不相同的因素经常在我们向加拿大和美国证券监管机构(包括美国证券交易委员会)提交的文件中讨论,这些文件可在www.sec.gov和加拿大证券管理人的网站和skylighthealthgroup.com上获得。

For more information, please visit our website or contact:

欲了解更多信息,请访问我们的网站或联系:

Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com416-301-2949  

投资者关系:
杰基·凯利
电子邮件:Investors@skylighthealthgroup.com416-301-2949

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所创业板交易所及其监管服务提供商(该术语在多伦多证券交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。


译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发